<html><head><script id="decision-support-view" type="application/json">{
  "dsViewId": "MELD.v1",
  "language": {
    "originalLanguage": {
      "terminologyId": {
        "name": "ISO_639-1",
        "value": "ISO_639-1"
      },
      "codeString": "en"
    }
  },
  "decisionSupportViewDefinitions": {
    "sv": {
      "name": "Model For End-Stage Liver Disease Score ",
      "description": "Uppskatta mortalitet hos patienter med terminal leversjukdom"
    },
    "en": {
      "name": "Model For End-Stage Liver Disease Score ",
      "description": "Mortality risk in patients with end-stage liver disease"
    }
  },
  "resourceDescription": {
    "originalAuthor": {
      "date": "2017-01-28",
      "name": "Eneimi Allwell-Brown",
      "organisation": "Cambio Healthcare Systems",
      "email": "info@cambio.se"
    },
    "otherContributors": [
      "Dennis Forslund, Cambio Healthcare Systems"
    ],
    "details": {
      "sv": {
        "purpose": "Att registrera data i enlighet med såväl senaste som ursprungliga versionen av MELD Score, vilken används för att på kort sikt uppskatta mortalitet hos patienter med terminal leversjukdom och därigenom bedöma behov av levertransplantation.",
        "keywords": [
          "levercirros",
          "leversvikt",
          "alkoholhepatit",
          "kronisk leversjukdom",
          "MELD",
          "MELD score",
          "cirros"
        ],
        "use": "Att registrera data i enlighet med såväl senaste som ursprungliga versionen av MELD Score, baserat på ett antal parametrar:\n\n- Kreatinin (mg/dl eller umol/L)\n- Totalt bilirubin (mg/dl eller umol/L)\n- Natrum (mmol/L)\n- International Normalized Ratio for prothrombin time (INR)\n- Huruvida patienten under senaste veckan genomgått dialys vid åtminstone två tillfällen eller CVVHD under minst 24 timmar\n\nFormel för ursprungliga MELD Score \u003d \u003d 9.57 * ln(kreatinin, mg/dL) + 3.78 * ln(bilirubin, mg/dL) + 11.20 * ln(INR) + 6.43; har patienten genomgått dialys sätts kreatininvärdet automatiskt till 4 mg/dl. \n\nFormel för senaste versionen av MELD score \u003d oMELD + [1.32 * (137-Na)] – [0.033 * oMELD * (137-Na)]; (baserat på referensvärde för natrium \u003d 125-137 mmol/L.)\n\nResultatet används för att uppskatta 90-dagarsmortalitet hos patienter med terminal leversjukdom, och registreras med hjälp av en separat arketyp - openEHR-EHR-EVALUATION.meld_score.v1.\n\nMELD Score är även användbar för att uppskatta överlevnad hos patienter med varicerblödning, levercirros kombinerat med infektion, fulminant leversvikt, alkoholhepatit och andra former av kronisk leversjukdom, samt för att prioritera behov av levertransplantation.",
        "misuse": "Endast avsedd för patienter över 12 års ålder. \n\nMELD Score är ej avsedd för att uppskatta mortalitet efter levertransplantation.",
        "copyright": "© Cambio Healthcare Systems"
      },
      "en": {
        "purpose": "To calculate the MELD score, used for predicting short-term mortality of end-stage liver disease, as well as organ transplant priority.",
        "keywords": [
          "end-stage liver disease",
          "Child-Turcotte-Pugh",
          "hepatic failure",
          "chronic liver disease",
          "CTP score"
        ],
        "use": "To calculate the MELD score and the Original MELD score, based on serum creatinine (mg/dl or umol/L), total serum bilirubin (mg/dl or umol/L), and serum sodium (mmol/L) concentrations, the International Normalized Ratio for prothrombin time (INR) and whether or not the individual has had at least two dialysis sessions or 24hrs of continuous venovenous hemodialysis (CVVHD) in the last week before serum creatinine was measured.\n\nOriginal MELD (oMELD) score \u003d 9.57 * ln(creatinine, mg/dL) + 3.78 * ln(bilirubin, mg/dL) + 11.20 * ln(INR) + 6.43; a positive history of dialysis automatically defaults serum creatinine concentration to 4 mg/dl.\nMELD score \u003d oMELD + [1.32 * (137-Na)] – [0.033 * oMELD * (137-Na)]; based on a normal serum sodium concentration of 125-137 mmol/L.\n\nThe calculated MELD score is used to determine the 90-day mortality in patients with end-stage liver disease, and that evaluation is done by the MELD_score_Assessment guide. MELD score is also accurate in predicting survival in patients with variceal bleeding, determining mortality in patients with cirrhosis who develop infections, predicting mortality in patients with fulminant hepatic failure, alcoholic hepatitis and other forms of chronic liver disease, as well as in prioritizing recipients of liver transplantation.",
        "misuse": "Not applicable for children under 12 years of age.\nMELD score is not useful for predicting mortality following liver transplantation.",
        "copyright": "© Cambio Healthcare Systems"
      }
    },
    "otherDetails": {
      "references": "Ref. 1: Chico-Fernández, M., García-Fuentes, C., Alonso-Fernández, M., Toral-Vázquez, D., Bermejo-Aznarez, S., \u0026 Alted-López, E. (2011). Massive transfusion predictive scores in trauma. Experience of a transfusion registry. Medicina Intensiva (English Edition), 35(9), 546-551.\n\nRef. 2: Subramaniam A, Albert V, Sharma S, et al.: Assessing the efficiency of scoring systems for predicting the probability of massive transfusion in trauma patients. J Haematol Thrombo Dis 2014; 2:1000161"
    }
  },
  "alertGuideIds": [],
  "executionGuideIds": [
    "MELD_score_Assessment.v1",
    "MELD_score_Calculation.v1"
  ],
  "alertBindings": {},
  "termDefinitions": {
    "sv": {
      "id": "sv",
      "terms": {
        "vt0001": {
          "id": "vt0001",
          "text": "Referenser"
        }
      }
    },
    "en": {
      "id": "en",
      "terms": {
        "vt0001": {
          "id": "vt0001",
          "text": "References"
        }
      }
    }
  }
}</script></head><body></body></html>